Patrick Hwu: What an inspiring time at ASCO24 with our team and over 40,000 peers

Patrick Hwu shared a post on X:

“What an inspiring time at the ASCO annual meeting with our team Moffitt Cancer Center and over 40,000 peers.  More than 80 team members in attendance

Science that will change practice
Countless connections with colleagues
So much hope for cancer patients everywhere

Coming together at the ASCO annual meeting is essential. Collaboration and the science shared these last few days will impact the many lives touched by cancer. Proud of our team and all the bright minds who contribute to this collective mission!”

Source: Patrick Hwu/X

Dr. Patrick Hwu, MD, currently serves as the President and CEO of Moffitt Cancer Center. With a focus on understanding the dynamics between tumors and the immune system, Dr. Hwu’s research has been pivotal in advancing gene-modified T cell therapy. He notably contributed seminal work on the development of the first chimeric antigen receptor aimed at combating cancer. His research portfolio extends to vaccines, adoptive T-cell therapies, and mechanisms of immune resistance.

Before joining, Dr. Hwu held numerous leadership roles at The University of Texas MD Anderson Cancer Center for over 17 years. Notably, he served as the inaugural Chairman of the Department of Melanoma Medical Oncology in 2003, as well as the Associate Director of the Center for Cancer Immunology Research. Additionally, he chaired the Department of Sarcoma Medical Oncology, demonstrating his commitment to advancing cancer treatment and research.